Younger age as a prognostic indicator in breast cancer: a cohort study. 2011

Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
Department of Surgery, National University of Ireland, Galway, Ireland. michael.kerin@nuigalway.ie

BACKGROUND The debate continues as to whether younger women who present with breast cancer have a more aggressive form of disease and a worse prognosis. The objectives of this study were to determine the incidence of breast cancer in women under 40 years old and to analyse the clinicopathological characteristics and outcome compared to an older patient cohort. METHODS Data was acquired from a review of charts and the prospectively reviewed GUH Department of Surgery database. Included in the study were 276 women diagnosed with breast cancer under the age of forty and 2869 women over forty. For survival analysis each women less than 40 was matched with two women over forty for both disease stage and grade. RESULTS The proportion of women diagnosed with breast cancer under the age of forty in our cohort was 8.8%. In comparison to their older counterparts, those under forty had a higher tumour grade (p = 0.044) and stage (p = 0.046), a lower incidence of lobular tumours (p < 0.001), higher estrogen receptor negativity (p < 0.001) and higher HER2 over-expression (p = 0.002); there was no statistical difference as regards tumour size (p = 0.477). There was no significant difference in overall survival (OS) for both groups; and factors like tumour size (p = 0.026), invasion (p = 0.026) and histological type (p = 0.027), PR (p = 0.031) and HER2 (p = 0.002) status and treatment received were independent predictors of OS CONCLUSION: Breast cancer in younger women has distinct histopathological characteristics; however, this does not result in a reduced survival in this population.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
January 2019, Breast cancer : basic and clinical research,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
March 1985, British medical journal (Clinical research ed.),
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
May 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
December 2001, British journal of cancer,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
January 1998, Anticancer research,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
June 1986, Cancer,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
August 1985, Cancer,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
August 2008, BMC cancer,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
January 1998, Anticancer research,
Elrasheid H A Kheirelseid, and Jennifer M E Boggs, and Catherine Curran, and Ronan W Glynn, and Cara Dooley, and Karl J Sweeney, and Michael J Kerin
December 2020, Scientific reports,
Copied contents to your clipboard!